
Validea's guru fundamental report indicates that UNITEDHEALTH GROUP INC (UNH) receives a 69% rating based on their Growth Investor model, which is based on the investment strategy of Martin Zweig. The model favors UNH due to its persistent accelerating earnings and sales growth, reasonable valuation, and low debt; however, the company fails certain tests related to earnings persistence and long-term EPS growth, according to the model's criteria.
UnitedHealth Group Inc. (UNH) has received a 69% rating from Validea's Growth Investor model, based on the strategy of Martin Zweig, which seeks growth stocks with persistent accelerating earnings and sales growth, reasonable valuations, and low debt. This score is below the 80% threshold typically indicating some interest from the strategy. UNH passed several criteria within this model, including its P/E ratio, revenue growth in relation to EPS growth, sales growth rate, current quarter earnings performance, positive earnings growth rate for the current quarter, and current quarter EPS growth exceeding both the prior three quarters and the historical growth rate. Insider transactions also met the model's criteria. However, the analysis highlights several weaknesses: UNH failed the tests for quarterly earnings compared to one year ago, the earnings growth rate over the past several quarters, overall earnings persistence, and long-term EPS growth. These failures suggest potential inconsistencies in maintaining accelerated earnings growth according to the specific parameters of the Zweig model, despite positive current-term indicators.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment